Literature DB >> 2317111

Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.

R A Asherson1, M Tikly, H Staub, P T Wilmshurst, D J Coltart, M Khamashta, G R Hughes.   

Abstract

Serum samples from 22 patients with infective endocarditis were analysed for the presence of antibodies to cardiolipin, false positive Venereal Disease Research Laboratory (VDRL) test, and rheumatoid factor in order to determine the prevalence of anticardiolipin antibodies, their level, and to ascertain whether there was any correlation with the presence of rheumatoid factor. Although the latex test was positive in 10/22 (45%) patients, anticardiolipin antibodies, usually of a low level, were raised in only four (18%), and the VDRL test was positive in two patients in whom other antibodies were negative. These results show a clear discordance between these three tests, indicating that B cell production of these antibodies is separate and distinct. As with other infections which result in anticardiolipin antibody production, no thrombotic events were encountered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317111      PMCID: PMC1003988          DOI: 10.1136/ard.49.2.107

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition?

Authors:  R P Messner; T Laxdal; P G Quie; R C Williams
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

2.  Lupus valvulitis necessitating double valve replacement.

Authors:  L Rawsthorne; M J Ptacin; H Choi; G N Olinger; V S Bamrah
Journal:  Arthritis Rheum       Date:  1981-03

3.  Rheumatological manifestations of infective endocarditis.

Authors:  P Thomas; J Allal; D Bontoux; F Rossi; J Y Poupet; J P Petitalot; B Becq-Giraudon
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

4.  Clinically significant valvular heart disease in systemic lupus erythematosus.

Authors:  K V Straaton; W W Chatham; J D Reveille; W J Koopman; S H Smith
Journal:  Am J Med       Date:  1988-11       Impact factor: 4.965

5.  Bacterial endocarditis complicating systemic lupus erythematosus.

Authors:  T J Lehman; S T Palmeri; C Hastings; J H Klippel; P H Plotz
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

6.  Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus.

Authors:  E Galve; J Candell-Riera; C Pigrau; G Permanyer-Miralda; H Garcia-Del-Castillo; J Soler-Soler
Journal:  N Engl J Med       Date:  1988-09-29       Impact factor: 91.245

7.  Clinical considerations regarding infective Libman-Sacks endocarditis.

Authors:  M P Tornos; E Galve; A Pahissa
Journal:  Int J Cardiol       Date:  1985-04       Impact factor: 4.164

8.  Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.

Authors:  R A Asherson; D G Gibson; D W Evans; E Baguley; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Rheumatic symptoms and signs in subacute infective endocarditis.

Authors:  J Azevedo; C Ribeiro; O Loureiro; A Cordeiro
Journal:  Eur Heart J       Date:  1984-10       Impact factor: 29.983

10.  Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis.

Authors:  K C Vaughton; D R Walker; M F Sturridge
Journal:  Br Heart J       Date:  1979-06
View more
  1 in total

Review 1.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.